Place of Origin:
Henan, China
Brand Name:
CXBT
Certification:
(2023) Veterinary Drug Production Certificate No.
Model Number:
Oral Solution Medicine
Oral Solution Medicine 30% Tilmicosin Oral Solution
Composition
Contains per ml:
Tilmicosin (as tilmicosin phosphate) 300 mg.
Excipients ad 1 ml.
Indications
This product is indicated for the control and treatment of respiratory infections associated with tilmicosin-susceptible micro-organisms such as Mycoplasma spp. Pasteurella multocida, Actinobacillus pleuropneumoniae, Actinomyces pyogenes and Mannheimia haemolytica in calves, chickens, turkeys and swine.
Contra indications
Hypersensitivity or resistance to tilmicosin.
Concurrent administration of other macrolides or lincosamides.
Administration to animals with an active microbial digestion or to equine or caprine species.
Parenteral administration, especially in porcine species.
Administration to poultry producing eggs for human consumption or to animals intended for breeding purposes.
During pregnancy and lactation, use only after a risk/benefit assessment by a veterinarian.
Side effects
Occasionally, a transient reduction in water or (artificial) milk intake has been observed upon treatment with tilmicosin.
Withdrawal times
- For meat:
Calves : 42 days.
Broilers : 12 days.
Turkeys : 19 days.
Swine : 14 days.
Dosage
For oral administration.
Calves:
Twice daily, 1 ml per 20 kg body weight via (artificial) milk for 3 - 5 days.
Poultry:
300 ml per 1000 litres of drinking water (75 ppm) for 3 days.
Swine:
800 ml per 1000 litres of drinking water (200 ppm) for 5 days.
Note: Medicated drinking water or (artificial) milk should be prepared fresh every 24 h. To ensure a correct dosage, the concentration of the product should be adjusted to the actual fluid intake.
If you need it, we can customize exclusive formulas, packaging, and everything you want for you. If you need a product manual, please contact us. Thank you.
Send your inquiry directly to us